OMZYRLI
Live / Allowed — Notice of allowance issued (as of 09 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99158471
- Mark type
- Stylized text
- Filed
- 28 Apr 2025
- Published for opposition
- 14 Oct 2025
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies
Owner
- Teva Pharmaceutical Industries Ltd., Tel Aviv, IL
- Teva Pharmaceutical Industries Ltd., Tel Aviv, IL
Prosecution history
- 04 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Feb 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 04 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Oct 2025 — PUBLISHED FOR OPPOSITION
- 08 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Sept 2025 — ASSIGNED TO EXAMINER
- 28 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 28 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Apr 2025 — NEW APPLICATION ENTERED